Favelle Favco a good dividend play

PETALING JAYA: MIDF Research believes there is no immediate re-rating catalysts for Favelle Favco Bhd but advised investors to remain invested in the company for its fair dividend payout.

“In light of the steep rise in share price, we believe that any further potential upside could be limited as there are no immediate re-rating catalysts for the stock.

“As such, we are downgrading Favelle Favco to ‘neutral’ from Buy previously with an unchanged target price of RM2.87 per share,” MIDF said.

The research house explained that its target on Favelle Favco was premised on EPS16 of 35.9sen pegged to price-to-earnings ratio (PER) 2016 of 8 times, which reflects its average monthly rolling PER for the past three years.

“We are advising shareholders to remain invested in Favco for its fair dividend payout of around 30% yielding approximately 3.8% per share,” it added.

The crane manufacturer has announced its first set of crane orders which was secured from December 2015 until now.

The six orders totalling RM64mil, consist of both offshore cranes and tower cranes. The company’s current orderbook is estimated at approximately RM750mil, implying a burn-rate of around three financial quarters.

MIDF explained that since November 2015, Favelle Favco’s share price had risen a meteoric 29.5% within a span of just two months. The stock price has also since breached our target price of RM2.87.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Business News

Ringgit seen trading range-bound at RM4.38-RM4.40 against US dollar next week Premium
CPO futures on cautious tone next week Premium
PetChem finds good fit in Sweden’s Perstorp Premium
Short Position - CPO prices, Green hydrogen in Malaysia Premium
Chin Hin Group continues M&A spree Premium
Recovery theme sustains short-term interest in M-REITs Premium
New vehicle sales down 3.6% in April Premium
Khazanah in S. Korean partnership with SK ecoplant Premium
Higher palm oil price boost for Sime Darby Premium
Pharmaniaga’s quarterly revenue rises 21.26% Premium

Others Also Read